PHARMAC is introducing four new medicines for cancer and preventing RSV in high-risk babies and young children.
It comes under its $604 million boost.
Patients with the type of advanced, non-small cell lung cancer and metastatic breast cancer will be able to access those cancer treatments.
Cancer Society Chief Executive Nicola Coom joins the show.
LISTEN ABOVE.
Take your Radio, Podcasts and Music with you
